Stocks RSKD Financial statements
Financial statementsRISKIFIED LTD. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data RISKIFIED LTD. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 131 | 170 | 229 | 261 | 298 | 328 | 345 |
| Cost of revenue | 64.9 | 76.9 | 106 | 126 | 145 | 157 | 167 |
| Gross profit | 65.7 | 92.8 | 123 | 135 | 153 | 171 | 178 |
| Research and development | 25 | 36.6 | 55.3 | 72 | 71.6 | 68.1 | 69.4 |
| Selling and marketing | 36.6 | 41.1 | 70.7 | 88.4 | 88.4 | 86.4 | 83.1 |
| General and administrative | 17.9 | 21.9 | 52.9 | 84 | 69.4 | 64.3 | 59.6 |
| Operating expenses | 79.6 | 99.6 | 179 | 244 | 229 | 219 | 212 |
| Operating income | -13.9 | -6.81 | -55.9 | -109 | -76.8 | -47.9 | -34 |
| Other non-operating income | 0.12 | -3.61 | -123 | 0.51 | 0.84 | -0.82 | -0.64 |
| Pre-tax income | -13.7 | -10.3 | -178 | -98.7 | -53.2 | -28.5 | -21.2 |
| Income tax | 0.48 | 1.08 | 1.56 | 6.04 | 5.8 | 6.42 | 6.36 |
| Net income | -14.2 | -11.3 | -179 | -105 | -59 | -34.9 | -27.6 |
| EBITDA | -13.2 | -5.45 | -54 | -106 | -73.3 | -44.5 | -31.6 |
| EPS, basic | 0.62 | ||||||
| EPS, diluted | 0.62 | ||||||
| Shares, basic (weighted) | 76.5 | 168 | 177 | 171 | 157 | ||
| Shares, diluted (weighted) | 76.5 | 168 | 177 | 171 | 157 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 69.7 | 104 | 418 | 189 | 441 | 371 | 162 |
| Short-term investments | 0 | 29 | 0 | 130 | |||
| Receivables | 37.2 | 35.5 | 37.5 | 46.9 | 47.8 | 48.5 | |
| Other current assets | 5.64 | 19.3 | 14.4 | 10.6 | 9.83 | 9.83 | |
| Total current assets | 163 | 565 | 530 | 532 | 434 | 356 | |
| Property, plant and equipment | 4.64 | 17 | 18.6 | 15.6 | 12.7 | 11 | |
| Lease right-of-use assets | 0 | 35.2 | 29.7 | 25.3 | 21.2 | ||
| Other non-current assets | 5.44 | 6.96 | 8.92 | 8.69 | 7.59 | 6.95 | |
| Total assets | 181 | 601 | 607 | 602 | 496 | 411 | |
| Accounts payable | 1.51 | 0.23 | 2.11 | 2.57 | 2.31 | 1.91 | |
| Accrued liabilities | 3.08 | 7.56 | 6.18 | 4.55 | 6.35 | 6.19 | |
| Total current liabilities | 51.9 | 62.4 | 72.6 | 69.8 | 70.5 | 70.7 | |
| Lease liabilities | 0 | 31.2 | 25.7 | 21.9 | 18.9 | ||
| Other non-current liabilities | 12.4 | 9.36 | 8.73 | 14.7 | 21.1 | 26.1 | |
| Total liabilities | 64.3 | 71.8 | 113 | 110 | 114 | 116 | |
| Paid-in capital | 24.4 | 775 | 849 | 916 | 982 | 1,029 | |
| Retained earnings | -67.7 | -248 | -353 | -412 | -446 | -474 | |
| Treasury stock | 0 | -13.2 | -154 | -260 | |||
| Other comprehensive income | 0 | 0.18 | -1.64 | 0.07 | 0.89 | -0.06 | |
| Shareholders' equity | -40.6 | -44 | 528 | 494 | 492 | 382 | 295 |
| Total equity | -40.6 | -44 | 528 | 494 | 492 | 382 | 295 |
| Total liabilities and equity | 181 | 601 | 607 | 602 | 496 | 411 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -14.2 | -11.3 | -179 | -105 | -59 | -34.9 | -27.6 |
| Depreciation and amortization | 0.72 | 1.36 | 1.99 | 3.61 | 3.57 | 3.35 | 2.46 |
| Stock-based compensation | 11.2 | 7.95 | 33.4 | 67.5 | 62.4 | 57.8 | 51.6 |
| Deferred income tax | 0.22 | 1.04 | 1.43 | -2.68 | -0.02 | 0.2 | -0.04 |
| Change in receivables | -3.28 | -12.6 | 1.44 | -1.72 | -9.69 | -1.85 | -1.36 |
| Change in payables | 2.68 | -3.71 | -0.83 | 1.93 | 0.37 | -0.2 | -0.38 |
| Cash from operations | 3.84 | -3.12 | -20.3 | -26.3 | 7.28 | 39.7 | 33.9 |
| Capital expenditures | -2.11 | -1.51 | -12.3 | -6.13 | -1.36 | -0.64 | -0.81 |
| Purchases of investments | 0 | -14 | 0 | 0 | -29.1 | 0 | -248 |
| Sales and maturities of investments | 0 | 0 | 28.3 | 116 | |||
| Cash from investing | -2.15 | -17 | -84.4 | -210 | 252 | 27.8 | -133 |
| Stock issued | 0.24 | 0.64 | 2.95 | 4.06 | 3.84 | 4.24 | 5.07 |
| Share buybacks | 0 | 0 | -13.2 | -141 | -106 | ||
| Cash from financing | 45.8 | 54 | 423 | 3.86 | -9.31 | -137 | -111 |
| Exchange rate effect | 0 | 0 | -1.7 | 0.3 | -0.4 | 0.72 | |
| Net change in cash | 47.5 | 33.9 | 318 | -234 | 250 | -69.8 | -209 |
| Free cash flow | 1.73 | -4.63 | -32.5 | -32.4 | 5.92 | 39.1 | 33.1 |
| Interest paid | 0.02 | 0 | 0 | 0 | 0 | ||
| Income taxes paid | 0 | 1.18 | 0.65 | 0.02 | 0 | 0.04 | 0.21 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 51.7% | Gross profit / revenue. |
| Operating margin | -9.9% | Operating income / revenue. |
| EBITDA margin | -9.2% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -6.2% | Pre-tax income / revenue. |
| Net margin | -8.0% | Net income / revenue. |
| FCF margin | 9.6% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 9.8% | Cash from operations / revenue. |
| Return on equity (ROE) | -8.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -6.1% | Net income / average total assets. |
| Return on invested capital (ROIC) | -37.4% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 20.1% | Research and development expense / revenue. |
| Stock-based pay / revenue | 15.0% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.2% | Capital expenditures / revenue. |
| D&A / revenue | 0.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 5.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 9.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 15.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 4.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 9.6% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 13.9% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -14.7% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -15.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | -22.9% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -15.8% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -17.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -12.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 17.9% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -7.9% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -2.1% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 5.03x | Current assets / current liabilities. |
| Quick ratio | 4.82x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 4.14x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 28.2% | Total liabilities / total assets. |
| Working capital | $285.1M | Current assets - current liabilities. |
| Tangible book value | $294.8M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.76x | Revenue / average total assets. |
| Fixed asset turnover | 29.1x | Revenue / average property, plant and equipment. |
| Receivables turnover | 7.16x | Revenue / average receivables. |
| Days sales outstanding | 51 days | 365 x average receivables / revenue. |
| Days payables | 5 days | 365 x average accounts payable / cost of revenue. |
| Capex / operating cash flow | 2.4% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue per share | $2.19 | Revenue / diluted weighted shares. |
| FCF per share | $0.21 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.22 | Cash from operations / diluted weighted shares. |
| Book value per share | $1.87 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.87 | Tangible book value / shares outstanding. |
| Cash per share | $1.86 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 321.2% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.15B | Share price x shares outstanding. |
| Enterprise value | $860.5M | Market cap + total debt - cash - short-term investments. |
| P/S | 3.35x | Market cap / revenue. |
| P/B | 3.91x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.91x | Market cap / tangible book value, when positive. |
| P/FCF | 34.9x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 34.0x | Market cap / cash from operations, when positive. |
| EV/Sales | 2.50x | Enterprise value / revenue. |
| EV/FCF | 26.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 2.9% | Free cash flow / market cap. |
| Earnings yield | -2.4% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 9.2% | (Dividends paid + share buybacks) / market cap. |
What was RISKIFIED LTD.'s revenue in fiscal 2025?
RISKIFIED LTD. reported revenue of $344.6M for fiscal 2025, 5.2% higher than the year before.
Was RISKIFIED LTD. profitable in fiscal 2025?
No. It reported a net loss of $27.6M.
How much free cash flow did RISKIFIED LTD. generate in fiscal 2025?
Cash from operations of $33.9M minus capital expenditures of $810.0K left free cash flow of $33.1M.